Eledon Pharmaceuticals

$42.8M revenue • 11 employees • United States

Last Updated May 21, 2025

Company Overview

Company Name

Eledon Pharmaceuticals

Address

United States

Website

eledon.com

Approx. Annual Revenue

$42.8M

Employees

11

Established

2000

About Eledon Pharmaceuticals

Eledon is a United States-based company with approximately 11 employees, established in 2000. The company is focused on developing its lead compound, tegoprubart, an anti-CD40L antibody with potential to improve the longevity and quality of life for transplant recipients. Eledon is currently conducting clinical trials for tegoprubart in kidney transplantation and exploring its potential in other organ transplantation, including liver and xenotransplantation.

Frequently Asked Questions about Eledon Pharmaceuticals

Technologies Used

Social Profiles

Key Decision Makers

David-Alexandre C. Gros CEO
LinkedIn
Rooke Hegarty Director Clinical Operations
LinkedIn
Brooke Hegarty Director Clinical Operations
LinkedIn
Hayley Robinson Senior Clinical Trial Manager
LinkedIn